Aehr Test Systems (AEHR) has drawn fresh attention after its share price closed at $93.62, with very large gains over the past 3 months and year to date, putting recent performance in sharp focus for investors.

At the current share price of $93.62, Aehr Test Systems has had a very strong 90 day share price return of 124.83% and an exceptional 1 year total shareholder return that is well above 8x. This signals strong recent momentum from the market.

If sharp moves in one semiconductor stock have caught your eye, this can be a useful moment to broaden your watchlist with other potential opportunities such as 47 AI infrastructure stocks

With the stock now well above the average analyst price target and backed by very strong recent returns, you need to ask whether Aehr Test Systems is undervalued or whether the market is already pricing in future growth.

Most Popular Narrative: 412.4% Overvalued

The most followed narrative for Aehr Test Systems puts fair value at $18.27, far below the last close at $93.62, which creates a wide valuation gap for investors to weigh.

AEHR may still have attractive technology and exposure to semiconductor growth markets. But the capital allocation record deserves as much scrutiny as the product story.

Want to understand why such a low fair value sits beneath a stock with very strong recent returns and revenue growth assumptions? The narrative leans heavily on forecasts for rapid top line expansion, persistent losses, and a rich future earnings multiple to reconcile today’s price. Curious how those moving parts line up to justify an overvaluation call this large? The full story unpacks the revenue path, margin profile, and required profitability shift behind that $18.27 figure.

Result: Fair Value of $18.27 (OVERVALUED)

However, there are risks that could challenge this overvaluation call, including stronger than expected revenue growth or a clearer path to sustained profitability that reshapes sentiment.

Next Steps

With sentiment clearly split between strong recent returns and valuation concerns, it helps to move quickly, test the numbers yourself, and weigh the 1 key reward and 2 important warning signs.

Looking for more investment ideas?

If Aehr Test Systems has sharpened your focus on opportunities, do not stop here. Broaden your watchlist now so you are not catching up later.

• Target potential value opportunities by checking out the 47 high quality undervalued stocks that match strong fundamentals with appealing valuations.
• Prioritize resilience by scanning the 62 resilient stocks with low risk scores designed to highlight companies with lower overall risk profiles.
• Hunt for under-the-radar potential via the screener containing 22 high quality undiscovered gems that surfaces quality stocks the crowd may be overlooking.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.